| BPN | bacitracin, polymyxin B, neomycin sulfate; brachial plexus neuropathy |
|---|---|
| PBN | paralytic brachial neuritis; peripheral benign neoplasm; polymyxin B sulfate, bacitracin, and neomyc... |
| BV | bacitracin V; bacterial vaginosis; biological value; blood vessel; blood volume; bronchovesicular |
| BX, bx | bacitracin X; biopsy |
| ung. | unguentum; ointment; 연고 |
| PB | Polymyxin B |
|---|---|
| PMX-B | Polymyxin B |
| PXB | Polymyxin B |
| PMBN | Polymyxin B nonapeptide |
| Cortisol | Hydrocortisone |
oleagenous ointment
| bacitracin | <protein> Branched cyclic peptides produced by strains of Bacillus licheniformis. Interfere with murein (peptidoglycan) synthesis in gram-positive bacteria. (18 Nov 1997) |
|---|---|
| bacitracin synthetase | <enzyme> Amino acids are activated through formation of aminoacyladenylates and then transferred to thioester sites before polymerization on the enzyme Registry number: EC 6.3.2.- (26 Jun 1999) |
| neomycin | <drug> Either of two aminoglycosides (B & C) produced by Streptomyces fradiae that have generalised antibiotic activity. Neomycin A (Ineamine) contains 2 deoxy 1,3 diamino inositol combined with the aminoglycoside. (18 Nov 1997) |
| neomycin sulfate | The sulfate of an antibacterial antibiotic substance produced by the growth of Streptomyces fradiae, active against a variety of Gram-positive and Gram-negative bacteria. (05 Mar 2000) |
| polymyxin | <chemical> Basic polypeptide antibiotic group obtained from bacillus polymyxa. They affect the cell membrane by detergent action and may cause neuromuscular and kidney damage. at least eleven different members of the polymyxin group have been identified, each designated by a letter. Pharmacological action: antibiotics, peptide. (12 Dec 1998) |
| polymyxin acylase | <enzyme> Deacylates polymyxin, colistin and octapeptin antibiotic Registry number: EC 3.5.1.- (26 Jun 1999) |
| polymyxin b | <chemical> A mixture of polymyxins b1 and b2, obtained from bacillus polymyxa strains. They are basic polypeptides of about eight amino acids and have cationic detergent action on cell membranes. Polymyxin b is used for infections with gram-negative organisms, but may be neurotoxic and nephrotoxic. Pharmacological action: antibiotics, peptide. Chemical name: Polymyxin B (12 Dec 1998) |
| polymyxin B sulfate | An antibacterial effective in tularaemia, brucellosis, Pseudomonas infections, and urinary tract infections, but used systemically only for severe infections not responsive to less toxic agents; it is also used locally. Polymyxin B is a mixture of polymyxin B1 and polymyxin B2. (05 Mar 2000) |
| hydrocortisone | <chemical> (11 beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione. The main glucocorticoid secreted by the adrenal cortex. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Pharmacological action: steroidal anti-inflammatory agents. Chemical name: Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)- (12 Dec 1998) |
| hydrocortisone acetate | Hydrocortisone 21-acetate;similar actions and uses as hydrocortisone. Synonym: cortisol acetate. (05 Mar 2000) |
| hydrocortisone cyclopentylpropionate | An ester of hydrocortisone. (05 Mar 2000) |
| hydrocortisone cypionate | The cyclopentanepropionic ester of cortisone, for oral administration. (05 Mar 2000) |
| hydrocortisone hydrogen succinate | A form of hydrocortisone administered intravenously. (05 Mar 2000) |
| hydrocortisone sodium phosphate | Hydrocortisone 21-(disodium phosphate);an anti-inflammatory agent for intravenous or intramuscular administration. (05 Mar 2000) |
| hydrocortisone sodium succinate | A very soluble ester salt of hydrocortisone (cortisol), used parenterally in the management of emergencies resulting from acute adrenal insufficiency. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|